Candriam S.C.A.

Q4 2022 13F-HR Holdings

Location
Strassen, Luxembourg, N4
Holdings as of
12/31/2022
Date filed
2/13/2023
Form type
13F-HR
Num holdings
866
Total value ($000)
$14,823,943
Net value change ($000)
+629,342 (4.4%)
New positions
51
Sold out positions
58
Turnover %
2.4%
Sector allocation + QoQ delta (equities-only)

Holdings aggregated across other managers listed in the original SEC filing. View detailed breakdown

Prev filing: 11/10/2022 Next filing: 5/12/2023 SEC filing

Snapshot: Change Analysis

Compared to Q3 2022
Methodology: sector metrics are equities-only; instrument mix chart is ex-options; options exposure is shown separately. Why this matters.
Top Adds (Value $000, Stocks/ETFs)
MRK 56,066 18.7%
MRNA 46,381 159.5%
MELI 42,500 65.4%
JNJ 41,074 50.7%
AMGN 39,588 18.2%
MET 36,581 136.3%
DAR 32,002 34.6%
V 31,936 24.2%
HD 28,777 38.9%
MSFT 28,482 3.8%
Top Reduces (Value $000, Stocks/ETFs)
TSLA -83,162 -43.7%
AAPL -67,338 -10.5%
PEP -38,927 -53.2%
PANW -33,365 -41.4%
GOOGL -30,575 -7.7%
CRM -28,201 -39.1%
ITW -25,077 -46.0%
Global Blood Therapeutics, Inc. -24,582 -100.0%
BRK-B -22,714 -100.0%
HAS -21,100 -86.0%
Instrument mix + QoQ Δ (ex-options)
Derivatives reported exposure ($000): 329 (0.0% of total reported value)
How this table is calculated: SEC VALUE ($000) is used as reported. For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received. Column % is bucket-based: non-options share is calculated inside non-option total, options share is calculated inside options total. Details.
Filter:
Instrument:
Issuer Name Ticker Sector Industry Class History Value ($000) % Shares Shares Δ Shares Δ% Value Δ ($000) Value Δ% Principal Option Type